Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Growth Paris  >  Novacyt    ALNOV   FR0010397232

NOVACYT

(ALNOV)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 11/25 12:15:18 pm
8.41 EUR   +4.99%
11/16NOVACYT S.A. : ("Novacyt", the "Company" or the “Group”) R&D Update
BU
10/15NOVACYT S.A. : Acquisition of IT-IS International Ltd
BU
10/15NOVACYT : Acquisition
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société NOVACYT
11/16NOVACYT S.A. : ("Novacyt", the "Company" or the “Group”) R&D Update
BU
10/15NOVACYT S.A. : Acquisition of IT-IS International Ltd
BU
09/29NOVACYT : Results of annual general meeting
PU
09/29NOVACYT S.A. :  New Contract With UK DHSC for Instrument Platforms and COVID-19 ..
BU
09/29NOVACYT : S.A. ("Novacyt :" or the "Company") Launch of COVID-19 Antibody Test
BU
09/17NOVACYT : Interim Accounts June 2020
PU
09/17NOVACYT : Rapport D'Activitie Semestriel 2020
PU
09/17NOVACYT S.A. ("NOVACYT", THE "COMPAN : Half Year 2020 Results
BU
09/15NOVACYT : Special Board report on resolutions
PU
09/10NOVACYT : Articles of Association
PU
09/07NOVACYT : The Board special report for EGM
PU
09/07NOVACYT : Form to request documents
PU
09/07NOVACYT : Company's activity during FY19
PU
09/04NOVACYT S.A. ("NOVACYT", THE "COMPAN : Launch of Two Gene COVID-19 Test
BU
08/27NOVACYT S.A. :  Launch of Respiratory Test Panel
BU
08/19NOVACYT : Avis de convocation à l'Assemblée générale des actionnaires
PU
07/27NOVACYT S.A. ("NOVACYT", THE "COMPAN : R&D Update
BU
07/22NOVACYT S.A. ("NOVACYT", THE "COMPAN : 2,000 Patient Clinical Trial Using Novacy..
BU
07/13NOVACYT S.A. ("NOVACYT", THE "COMPAN : Half-Year Trading Update
BU
06/30NOVACYT : AGM results July 2019
PU
06/30NOVACYT : Annual Report and Accounts for the year ended 2019
PU
06/18NOVACYT S.A. :  Launch of Three Innovative Products to Support COVID-19 Testing
BU
06/03NOVACYT S.A. : Early Settlement of Term Loan and Convertible Bond Facility Remov..
BU
06/02NOVACYT S.A. ("NOVACYT", THE "COMPAN : Coronavirus Update
BU
05/14NOVACYT : Management Report 31122019
PU
05/14NOVACYT S.A. :  Final Results for the Year Ended 31 December 2019 and Outlook fo..
BU
04/29NOVACYT S.A. ("NOVACYT" OR THE "COMP : Coronavirus Test Update and Notification ..
BU
04/27NOVACYT S.A. : Contract with UK Department of Health and Social Care for Supply ..
BU
04/15NOVACYT S.A. : Manufacturing and R&D update for COVID-19 test
BU
04/08NOVACYT S.A. ("NOVACYT" OR THE "COMP : COVID-19 Test Eligible for WHO Emergency ..
BU
04/08NOVACYT : Collaboration with AstraZeneca, GSK and University of Cambridge to sup..
BU
04/06NOVACYT : S.A. ("Novacyt :" or the "Company") COVID-19 Diagnostic Regulatory Upd..
BU
03/30NOVACYT : S.A. ("Novacyt :" or the "Company") Coronavirus Test Update
BU
03/25NOVACYT S.A. : Contract manufacturing services agreement signed with Yourgene He..
BU
03/25NOVACYT S.A. : Global Distribution Agreement With Bruker for COVID-19 Diagnostic..
BU
03/23NOVACYT S.A. ("NOVACYT" OR THE "COMP : US FDA Emergency Use Authorization for CO..
BU
03/20NOVACYT S.A. : Coronavirus test update
BU
03/16NOVACYT : Price Monitoring Extension
PU
03/16NOVACYT S.A. :  Coronavirus test update
BU
03/12NOVACYT : Coronavirus test update
PU
03/12NOVACYT S.A. : Coronavirus test update
BU
03/06NOVACYT : Second Price Monitoring Extn
PU
03/05NOVACYT : Notification of major holding - 5th March 2020
PU
02/28NOVACYT : Coronavirus test update
PU
02/28NOVACYT S.A. : Coronavirus Test Update
BU
02/19NOVACYT : Final Warrant Exercise and Issue of Equity
PU
02/18NOVACYT : Exercise of Warrants and Issue of Equity
PU
02/17NOVACYT : Launch of CE-IVD Marked novel coronavirus test
PU
02/17NOVACYT S.A. : Launch of CE-IVD Marked novel coronavirus test
BU
02/17NOVACYT : Price Monitoring Extension
PU
02/17NOVACYT : Second Price Monitoring Extn
PU
02/14NOVACYT S.A. : Update on CE Mark Approved coronavirus test
BU
02/14NOVACYT : Update on CE Mark Approved coronavirus test
PU
02/14NOVACYT : Price Monitoring Extension
PU
02/07NOVACYT : Update on novel coronavirus test
PU
02/07NOVACYT S.A. :  Update on Novel Coronavirus Test
BU
02/03NOVACYT : Second Price Monitoring Extn
PU
02/03NOVACYT : Price Monitoring Extension
PU
01/31NOVACYT S.A. :  Launch of Novel Coronavirus Test
BU
01/28NOVACYT S.A. : Full Year Trading and Operational Update
BU
01/17NOVACYT S.A. :  Primerdesign Partners With VGS Group in France
BU
2019NOVACYT S.A. : ("Novacyt", the "Company" or the “Group”) Completion ..
BU
2019NOVACYT : Information mensuelle sur le contrat de liquidité et sur le nombre tot..
PU
2019NOVACYT S.A. :  New Term Loan and Termination of Convertible Bond Facility
BU
2019NOVACYT S.A. : New Molecular Respiratory Panel Ready for the US Market
BU
2019NOVACYT : Interim Accounts June 2019
PU
2019NOVACYT : Rapport D'Activitie Semestriel 2019
PU
2019NOVACYT : Follow-up chart relating to the OCABSA agreement 26th September 2019
PU
2019NOVACYT : 2019 half-year results
PU
2019NOVACYT S.A. :  Half Year Results
BU
2019NOVACYT : 2018 half-year results
PU
2019NOVACYT S.A. : Half-Year Trading Update
BU
2019NOVACYT S.A. : Sale of Clinical Lab
BU
2019NOVACYT : Follow-up chart relating to the OCABSA agreement 25th June 2019
PU
2019NOVACYT : Follow-up chart relating to the OCABSA agreement 19th June 2019
PU
1  2Next